Title:
Latex agglutination tests for rapid, instrument-free COVID-19 diagnostics in saliva (Phase 2)
Agreement Value:
$170,000.00
Agreement Date:
Mar 25, 2021 - Sep 9, 2021
Description:
The Project is to optimize unique latex agglutination tests (LATs) for the detection of SARS-CoV-2 virus in saliva in an inexpensive "chewable diagnostic" format. The LATs for SARS-CoV-2 are to be performed in a single step, with the aim that the results will be readable by visual inspection, with the potential for automated readout via a smart-phone. By the end of this Project, LATs implemented in the chewable cartridge format will have been developed, optimized, and evaluated in a pilot scale clinical trial.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Toronto, Ontario, CA M5G 1L5
Reference Number:
172-2020-2021-Q4-969766
Report Type:
Grants and Contributions
Recipient Business Number:
108162330
Additional Information:
Belated reporting: This agreement has been amended 1 time(s). The end date of this agreement has been modified by -53 days.
Amendment Date
Nov 9, 2021
Recipient's Legal Name:
The Governing Council of the University of Toronto
Federal Riding Name:
University–Rosedale
Federal Riding Number:
35110
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.